Ceryvyn Therapeutics (ASX:CYV) Beginning Cash Position: A$-0.00 Mil (As of Jun. 2025)


What is Ceryvyn Therapeutics Beginning Cash Position?

Ceryvyn Therapeutics ASX:CYV -7.69% Beginning Cash Position is A$-0.00 Mil as of Jun. 2025. The stock has 3 warning signs investors should review.

Ceryvyn Therapeutics's Beginning Cash Position for the quarter that ended in Jun. 2025 was A$-0.00 Mil.

Ceryvyn Therapeutics's quarterly Beginning Cash Position increased from Jun. 2024 (A$236.55 Mil) to Dec. 2024 (A$272.33 Mil) but then declined from Dec. 2024 (A$272.33 Mil) to Jun. 2025 (A$-0.00 Mil).

Ceryvyn Therapeutics's annual Beginning Cash Position increased from Jun. 2023 (A$66.50 Mil) to Jun. 2024 (A$134.32 Mil) and increased from Jun. 2024 (A$134.32 Mil) to Jun. 2025 (A$264.92 Mil).

Ceryvyn Therapeutics Beginning Cash Position Related Terms

Ceryvyn Therapeutics Beginning Cash Position Historical Data

* Premium members only.

The historical data trend for Ceryvyn Therapeutics's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ceryvyn Therapeutics Beginning Cash Position Chart

Ceryvyn Therapeutics Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Beginning Cash Position
Get a 7-Day Free Trial Premium Member Only Premium Member Only 55.79 168.19 66.50 134.32 264.92

Ceryvyn Therapeutics Semi-Annual Data
Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25
Beginning Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 211.24 133.25 236.55 272.33 -0.00

Ceryvyn Therapeutics Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

What does a Beginning Cash Position of A$-0.00 Mil mean?
Ceryvyn Therapeutics (ASX:CYV) has a Beginning Cash Position of A$-0.00 Mil as of Jun. 2025. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on Ceryvyn Therapeutics and its competitors.
Is Ceryvyn Therapeutics' Beginning Cash Position too high?
Ceryvyn Therapeutics' current Beginning Cash Position is A$-0.00 Mil.
How does Ceryvyn Therapeutics' Beginning Cash Position compare to VRTX and REGN?
Ceryvyn Therapeutics' Beginning Cash Position of A$-0.00 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beginning Cash Position for a Biotechnology company?
A good Beginning Cash Position depends on the Biotechnology industry context. However, Beginning Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beginning Cash Position mean?
A high Beginning Cash Position can signal that a stock is expensive relative to its fundamentals. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on Ceryvyn Therapeutics and its competitors. Ceryvyn Therapeutics's current Beginning Cash Position is A$-0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ceryvyn Therapeutics stock overvalued right now?
Ceryvyn Therapeutics (ASX:CYV) has a current Beginning Cash Position of A$-0.00 Mil. The current Beginning Cash Position is A$-0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beginning Cash Position calculated?
Beginning Cash Position is calculated from a company's financial statements. For Ceryvyn Therapeutics (ASX:CYV), the current Beginning Cash Position is A$-0.00 Mil as of Jun. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Ceryvyn Therapeutics Business Description

Address C/ Prime Company Compliance, 505 Little Collins Street, Level 9, Melbourne, VIC, AUS, 3000
Opthea Ltd is engaged in researching and developing novel therapeutic products that target Vascular Endothelial Growth Factors (VEGF) C, D, and R3. The Group operates in one industry and two geographical areas, namely biotechnology and healthcare, with operations in Australia and the United States. The company focuses on developing biological therapeutics for eye diseases and is currently developing a novel biologic therapy, OPT-302, for the treatment of eye conditions. Its products are based on an intellectual property portfolio covering VEGF-C, VEGF-D, and VEGF Receptor-3 targets, aimed at treating diseases associated with blood and lymphatic vessel growth and vascular leakage.